A portrayal of E3 ubiquitin ligases and deubiquitylases in cancer

被引:43
|
作者
Satija, Yatendra Kumar [1 ]
Bhardwaj, Abhishek [1 ]
Das, Sanjeev [1 ]
机构
[1] Natl Inst Immunol, Mol Oncol Lab, New Delhi 110067, India
关键词
cancer; p53; ubiquitylation; proteasome; TUMOR-SUPPRESSOR GENE; CELL-CYCLE CONTROL; DEUBIQUITINATING ENZYME USP2A; FATTY-ACID SYNTHASE; RING-FINGER DOMAIN; DNA-DAMAGE; BETA-TRCP; MEDIATED DEGRADATION; PROSTATE-CANCER; PROTEIN LIGASE;
D O I
10.1002/ijc.28129
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
E3 ubiquitin ligases and deubiquitylating enzymes (DUBs) are the key components of ubiquitin proteasome system which plays a critical role in cellular protein homeostasis. Any shortcoming in their biological roles can lead to various diseases including cancer. The dynamic interplay between ubiquitylation and deubiquitylation determines the level and activity of several proteins including p53, which is crucial for cellular stress response and tumor suppression pathways. In this review, we describe the different types of E3 ubiquitin ligases including those targeting tumor suppressor p53, SCF ligases and RING type ligases and accentuate on biological functions of few important E3 ligases in the cellular regulatory networks. Tumor suppressor p53 level is tightly regulated by multiple E3 ligases including Mdm2, COP1, Pirh2, etc. SCF ubiquitin ligase complexes are key regulators of cell cycle and signal transduction. BRCA1 and VHL RING type ligases function as tumor suppressors and play an important role in DNA repair and hypoxia response respectively. Further, we discuss the biological consequences of deregulation of the E3 ligases and the implications for cancer development. We also describe deubiquitylases which reverse the process of ubiquitylation and regulate diverse cellular pathways including metabolism, cell cycle control and chromatin remodelling. As the E3 ubiquitin ligases and DUBs work in a substrate specific manner, an improved understanding of them can lead to better therapeutics for cancer.
引用
收藏
页码:2759 / 2768
页数:10
相关论文
共 50 条
  • [21] E3 ubiquitin ligases for MHC molecules
    Ishido, Satoshi
    Goto, Eiji
    Matsuki, Yohei
    Ohmura-Hoshino, Mari
    CURRENT OPINION IN IMMUNOLOGY, 2009, 21 (01) : 78 - 83
  • [22] RBR E3 ubiquitin ligases in tumorigenesis
    Wang, Peter
    Dai, Xiaoming
    Jiang, Wenxiao
    Li, Yuyun
    Wei, Wenyi
    SEMINARS IN CANCER BIOLOGY, 2020, 67 : 131 - 144
  • [23] Protein Degradation by E3 Ubiquitin Ligases in Cancer Stem Cells
    Quiroga, Macarena
    Rodriguez-Alonso, Andrea
    Alfonsin, Gloria
    Rodriguez, Juan Jose Escuder
    Breijo, Sara M.
    Chantada, Venancio
    Figueroa, Angelica
    CANCERS, 2022, 14 (04)
  • [24] The involvement of E3 ubiquitin ligases in the development and progression of colorectal cancer
    Chen, Jie
    Feng, Haimei
    Wang, Yiting
    Bai, Xiaoming
    Sheng, Siqi
    Li, Huiyu
    Huang, Mengxi
    Chu, Xiaoyuan
    Lei, Zengjie
    CELL DEATH DISCOVERY, 2023, 9 (01)
  • [25] Potential of E3 Ubiquitin Ligases in Cancer Immunity: Opportunities and Challenges
    Ye, Peng
    Chi, Xiaoxia
    Cha, Jong-Ho
    Luo, Shahang
    Yang, Guanghui
    Yan, Xiuwen
    Yang, Wen-Hao
    CELLS, 2021, 10 (12)
  • [26] The functional analysis of Cullin 7 E3 ubiquitin ligases in cancer
    Shi, Le
    Du, Dongyue
    Peng, Yunhua
    Liu, Jiankang
    Long, Jiangang
    ONCOGENESIS, 2020, 9 (10)
  • [27] The emerging roles of E3 ubiquitin ligases in ovarian cancer chemoresistance
    Meng, Yang
    Qiu, Lei
    Zhang, Su
    Han, Junhong
    CANCER DRUG RESISTANCE, 2021, 4 (02) : 365 - 381
  • [28] The SCF-type E3 Ubiquitin Ligases as Cancer Targets
    Kitagawa, Kyoko
    Kitagawa, Masatoshi
    CURRENT CANCER DRUG TARGETS, 2016, 16 (02) : 119 - 129
  • [29] Emerging roles of the HECT E3 ubiquitin ligases in gastric cancer
    Sun, Aiqin
    Tian, Xianyan
    Chen, Yifei
    Yang, Wannian
    Lin, Qiong
    PATHOLOGY & ONCOLOGY RESEARCH, 2023, 29
  • [30] The roles of E3 ubiquitin ligases in cancer progression and targeted therapy
    Sampson, Chibuzo
    Wang, Qiuping
    Otkur, Wuxiyar
    Zhao, Haifeng
    Lu, Yun
    Liu, Xiaolong
    Piao, Hai-long
    CLINICAL AND TRANSLATIONAL MEDICINE, 2023, 13 (03):